Virginia National Bank Amgen Inc Transaction History

Virginia National Bank

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 09, 2019	SELL	$180.87 - $203.88 $294,818 - $332,324	-1,630 Closed	0 $0
Q4 2018 Jan 24, 2019	SELL	$178.4 - $208.25 $8,028 - $9,371	-45 Reduced 2.69%	1,630 $317,000
Q3 2018 Nov 15, 2018	BUY	$185.29 - $208.89 $310,360 - $349,890	1,675 New	1,675 $347,000

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Virginia National Bank, based on Form 13F filings with the SEC.

Stay updated on Virginia National Bank with notifications on news.